U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07195253) titled 'Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome' on Sept. 02.
Brief Summary: Obstructive Sleep Apnea (OSA) is characterised by repetitive collapse of the upper airway during sleep, inducing breathing disturbances that can result in oxygen desaturation and frequent arousals. In children, OSA can have long-term consequences on the development and on the cardiovascular system.
Down Syndrome (DS) is a genetic disorder associated with intellectual disability and many comorbidities. The prevalence of OSA is particularly high in patients with DS, from infancy. In a recent study by Fauroux et al...